Just emerged from Forward Pharma. It will be a battle. Likely they cut a deal with Forward that gives Forward significant royalties on Tecfidera's $2.9B in sales, or they potentially lose IP protection on their blockbuster. Not good either way.
Expect major profit taking today by institutionals who just took a $20+ gain